We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$718B
AUM Growth
+$49.7B
Cap. Flow
-$15.6B
Cap. Flow %
-2.17%
Top 10 Hldgs %
31.75%
Holding
3,044
New
123
Increased
1,636
Reduced
968
Closed
150

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.11B
2
META icon
Meta Platforms (Facebook)
META
+$2.59B
3
EQT icon
EQT Corp
EQT
+$1.31B
4
CL icon
Colgate-Palmolive
CL
+$1.08B
5
ADBE icon
Adobe
ADBE
+$1.06B

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.92B
2
UNH icon
UnitedHealth
UNH
+$1.78B
3
AMD icon
Advanced Micro Devices
AMD
+$1.55B
4
ROST icon
Ross Stores
ROST
+$1.54B
5
ASML icon
ASML
ASML
+$1.49B

Sector Composition

Rank Sector Weight
1 Technology 31.61%
2 Healthcare 16.91%
3 Consumer Discretionary 11.05%
4 Financials 10.6%
5 Communication Services 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVAV icon
1601
AeroVironment
AVAV
$9.68B
$1.48M ﹤0.01%
14,454
-284
-2% -$28.6K
AXSM icon
1602
Axsome Therapeutics
AXSM
$11.3B
$1.47M ﹤0.01%
20,476
+4,227
+26% +$312K
BRC icon
1603
Brady Corp
BRC
$4.45B
$1.47M ﹤0.01%
30,900
-8,565
-22% -$431K
ROG icon
1604
Rogers Corp
ROG
$2.54B
$1.47M ﹤0.01%
9,058
+120
+1% +$19K
DBRG icon
1605
DigitalBridge
DBRG
$2.94B
$1.46M ﹤0.01%
99,452
+5,836
+6% +$71.6K
ABM icon
1606
ABM Industries
ABM
$2.82B
$1.46M ﹤0.01%
34,229
+791
+2% +$34.3K
NUVB icon
1607
Nuvation Bio
NUVB
$2.16B
$1.45M ﹤0.01%
805,819
-48,848
-6% -$83K
DIN icon
1608
Dine Brands
DIN
$442M
$1.45M ﹤0.01%
24,974
+3,793
+18% +$242K
ABCB icon
1609
Ameris Bancorp
ABCB
$6B
$1.45M ﹤0.01%
42,346
-15,352
-27% -$509K
FTAI icon
1610
FTAI Aviation
FTAI
$22.2B
$1.45M ﹤0.01%
45,723
+25,865
+130% +$733K
CRI icon
1611
Carter's
CRI
$1.41B
$1.45M ﹤0.01%
19,931
-196
-1% -$13.2K
BNL icon
1612
Broadstone Net Lease
BNL
$4.37B
$1.44M ﹤0.01%
93,079
+6,922
+8% +$111K
LXP icon
1613
LXP Industrial Trust
LXP
$3.57B
$1.44M ﹤0.01%
29,485
+1,011
+4% +$50K
BXMT icon
1614
Blackstone Mortgage Trust
BXMT
$2.43B
$1.44M ﹤0.01%
68,920
+1,979
+3% +$36.4K
ZG icon
1615
Zillow
ZG
$7.92B
$1.42M ﹤0.01%
28,936
-1,141
-4% -$51.4K
IIPR icon
1616
Innovative Industrial Properties
IIPR
$1.63B
$1.42M ﹤0.01%
19,476
+367
+2% +$25.8K
IOSP icon
1617
Innospec
IOSP
$2.31B
$1.42M ﹤0.01%
14,146
+810
+6% +$81.1K
ECPG icon
1618
Encore Capital Group
ECPG
$2.18B
$1.41M ﹤0.01%
29,051
+1,443
+5% +$70.2K
SYNH
1619
PUT
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.41M ﹤0.01%
+33,400
New +$1.35M
NGVT icon
1620
Ingevity
NGVT
$2.61B
$1.4M ﹤0.01%
24,110
-278,069
-92% -$16.7M
BHF icon
1621
Brighthouse Financial
BHF
$3.39B
$1.39M ﹤0.01%
29,395
-2,735
-9% -$118K
MAC icon
1622
Macerich
MAC
$6.98B
$1.39M ﹤0.01%
123,438
+2,736
+2% +$27.9K
FWRD icon
1623
Forward Air
FWRD
$636M
$1.39M ﹤0.01%
13,100
+2,251
+21% +$230K
VRNS icon
1624
Varonis Systems
VRNS
$5.16B
$1.39M ﹤0.01%
52,011
+1,324
+3% +$33.1K
UCB
1625
United Community Banks
UCB
$4.42B
$1.39M ﹤0.01%
55,386
+3,077
+6% +$76.4K

Similar funds

T. Rowe Price Associates's Q2 2023 Portfolio in Review

As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
  • T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
  • T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
  • T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
  • T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
  • T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.